Inari Medical, Inc. (NARI) Tops Q3 EPS by 6c

Inari Medical, Inc. (NASDAQ: NARI) reported Q3 EPS of ($0.19), $0.06 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $96.2 million versus the consensus estimate of $90.79 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)